Literature DB >> 3583682

Human arginase isozymes.

W W Grody, G J Dizikes, S D Cederbaum.   

Abstract

Studies in experimental animals and humans demonstrate the existence of two arginase isozymes. One, designated AI (or A1), has a high pI, is located in the cytosol, is most abundant in liver, and is thought to be primarily responsible for ammonia detoxification as urea. The gene coding for this isozyme is mutated in human hyperargininemia. A second isozyme, designated AII (or A4), has a neutral pI, is located in the mitochondrial matrix, and is thought to be involved primarily in the production of ornithine as a precursor of proline and glutamate. It appears to be expressed in most but not all tissues and in more nearly equal amounts. The two isozymes are immunologically distinct and are coded for by two separate genes. The great similarity in all measured kinetic and some physicochemical properties implies a high degree of structural similarity at the active site, but the lack of immunological cross-reactivity and DNA cross-hybridization implies substantial compositional differences in other parts of the enzyme molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3583682

Source DB:  PubMed          Journal:  Isozymes Curr Top Biol Med Res        ISSN: 0160-3787


  11 in total

1.  Molecular genetic study of human arginase deficiency.

Authors:  W W Grody; D Klein; A E Dodson; R M Kern; P B Wissmann; B K Goodman; P Bassand; B Marescau; S S Kang; J V Leonard
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Binding of α,α-disubstituted amino acids to arginase suggests new avenues for inhibitor design.

Authors:  Monica Ilies; Luigi Di Costanzo; Daniel P Dowling; Katherine J Thorn; David W Christianson
Journal:  J Med Chem       Date:  2011-07-18       Impact factor: 7.446

3.  2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I.

Authors:  Monica Ilies; Luigi Di Costanzo; Michelle L North; Jeremy A Scott; David W Christianson
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin.

Authors:  Lacy A Holowatz; Caitlin S Thompson; W Larry Kenney
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

5.  Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB.

Authors:  Vera Barra; Anne-Marie Kuhn; Andreas von Knethen; Andreas Weigert; Bernhard Brüne
Journal:  Cell Mol Life Sci       Date:  2010-10-15       Impact factor: 9.261

6.  Effect of rosuvastatin on arginase enzyme activity and polyamine production in experimental breast cancer.

Authors:  Hakan Erbaş; Oğuz Bal; Erol Çakır
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 7.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

8.  Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin.

Authors:  Jennifer M Bratt; Lisa M Franzi; Angela L Linderholm; Michael S Last; Nicholas J Kenyon; Jerold A Last
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-05       Impact factor: 4.219

9.  Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma.

Authors:  Jennifer M Bratt; Amir A Zeki; Jerold A Last; Nicholas J Kenyon
Journal:  J Biomed Res       Date:  2011-09

10.  Regulation of nitric oxide generation by up-regulated arginase I in rat spinal cord injury.

Authors:  Takashi Imagama; Keiki Ogino; Kei Takemoto; Yoshihiko Kato; Hideo Kataoka; Hidenori Suzuki; Zhang Ran; Heri Setiawan; Yoshihisa Fujikura; Toshihiko Taguchi
Journal:  J Clin Biochem Nutr       Date:  2012-02-18       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.